32140sek
-2,3 %
Date:2026-04-17Time:18:00:00Latest report:Q4-2025List:Large CapTicker:BIOA B
Market Cap:28 514 msekEnterprise Value:26 368 msekNet Sales:1 999 msekEarnings:1 022 msekEmployees:0ISIN:SE0010323311

Ratios

10-year key figure history for BioArctic turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for BioArctic with index and moving average MA50 and MA200.

Stockprice:321,40
MA50:318,52
MA200:288,49
Price/MA200:11,4 %
RSI (14):51,2
Price/MA50:0,9 %

Description

BioArctic is a biopharmaceutical company focused on developing new treatments that address the causes of neurodegenerative diseases. Examples of diseases include Alzheimer's and Parkinson's. A large part of the research is carried out in collaboration with researchers at universities and hospitals. BioArctic was founded in 2003 and is headquartered in Stockholm.

Biotechnology